The MBI checklist (MBI-C) was developed for research and has not been validated for clinical diagnosis and assessment. Validation studies are ongoing with respect to scoring and prognostication. Collaborations on MBI research and validation are welcome--please contact us for details. The MBI-C is provided “as is” without representations of any kind, and whoever owns this invention expressly disclaims any warranty or condition, express or implied, statutory or otherwise, including, without limitation, any warranty that the MBI-C (a) are fit for a particular purpose, (b) are durable for a reasonable period of time, or (c) does not and will not infringe any patent, trade-mark, trade secret or other intellectual property or other proprietary right of any third party.
The checklist is designed to quantify the severity of behavioural symptoms in multiple domains. Global and domain-specific scores and thresholds have not yet been developed and validated for clinical diagnosis and prognosis. Ongoing validation work will identify scores and thresholds that predict an increased risk of transition to dementia. The website will be updated with results of validation as they are completed.
For further information on MBI and the MBI-C, and for collaborations, validations or licensing, please contact Dr. Zahinoor Ismail at the email below.
Zahinoor Ismail MD FRCPC Hotchkiss Brain Institute, University of Calgary